Related references
Note: Only part of the references are listed.Mutations in IL36RN/IL1F5 Are Associated with the Severe Episodic Inflammatory Skin Disease Known as Generalized Pustular Psoriasis
Alexandros Onoufriadis et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Interleukin-36-Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
Slaheddine Marrakchi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation
Hal Blumberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
In vitro and in silico analysis reveals an efficient algorithm to predict the splicing consequences of mutations at the 5′ splice sites
Kentaro Sahashi et al.
NUCLEIC ACIDS RESEARCH (2007)
Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-κB and MAPKs
JE Towne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Two novel IL-1 family members, IL-1δ and IL-1ε, function as an antagonist and agonist of NF-κB activation through the orphan IL-1 receptor-related protein 2
R Debets et al.
JOURNAL OF IMMUNOLOGY (2001)
Four new members expand the interleukin-1 superfamily
DE Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
